Filter by category



Tissue Type






MTF Biologics Expands Plastic Surgery Portfolio with LipoGrafter®

Edison, N.J., November 30, 2017 –
MTF Biologics is expanding its offerings for plastic surgeons with the introduction of a practical solution for large-volume fat grafting designed for better graft survival: LipoGrafter®. This easy-to-use technology offers surgeons a safe and efficient way to harvest a patient’s fat and deposit it in areas where the patient may be seeking to add volume.

“MTF Biologics is dedicated to offering surgeons innovative technologies and solutions that help them better serve their patients,” said Tom Shaffer, Executive Vice-President, Global Sales & Marketing at MTF Biologics. “In many cases, this involves innovations from our internal R&D and Processing teams. In others, it involves partnering with talented individuals and organizations outside of MTF Biologics to develop and commercialize novel and innovative solutions. As we continue to expand the many ways we work with and serve those in plastic and reconstructive surgery, we are proud to be able to deliver LipoGrafter, a revolutionary fat grafting system, to patients and plastic surgeons around the world.”

A time-saving fat grafting solution, LipoGrafter facilitates both harvesting and depositing of autologous fat grafts with fewer connections for ease of assembly and use. As a closed system, the LipoGrafter technology reduces the risk of graft contamination. The device was designed with improved graft survival in mind and is based on well-accepted principles of fat grafting. Each sterile, single-use LipoGrafter disposable kit contains a KVAC® syringe for a constant spring-activated vacuum pull force during harvesting, four collection bags, a multi-port AT-Valve® designed to interface with the various components, and a tubing set with connectors.

LipoGrafter is part of a portfolio of innovations that MTF Biologics has introduced to maximize the use of fat in plastic and reconstructive surgery. The organization also offers Renuva®, an allograft adipose matrix that is engineered to conveniently treat small volume soft tissue defects, liposuction defects, and cellulite dimples.

About MTF Biologics
MTF Biologics, also known as the Musculoskeletal Transplant Foundation (MTF), is a nonprofit organization based in Edison, N.J. It is a national consortium comprised of leading organ procurement organizations, tissue recovery organization and academic medical institutions, and governed by a board of surgeons who are leading experts in tissue transplantation. As the world’s largest tissue bank, MTF Biologics saves and heals lives by honoring donated gifts, serving patients and advancing science. Since its inception in 1987, the organization has received tissue from more than 120,000 donors and distributed more than 7.5 million allografts for transplantation. Through its IIAM subsidiary, it has placed more than 55,000 non-transplantable organs for research. Through its Statline subsidiary, it has managed more than 10 million donor referrals.